Account
Publicis wins Heineken India account
MUMBAI: Publicis has won the Heineken India business after a three-way agency pitch. The account was earlier with Wieden + Kennedy.
Publicis will handle the account of their Bangalore office. The brand will retain its ‘One World. One Heineken’ ideology
Speaking of the win in a joint statement, Publicis Worldwide South Asia CEO Nakul Chopra and Publicis Worldwide MD South Asia Bobby Pawar said, “Partnering an iconic brand like Heineken is a dream opportunity. We are honoured to have been chosen. We look forward to collaborating with them to create world class engagement ideas.”
United Breweries marketing SVP Samar Singh Sheikhawat added, “We are delighted to partner with Publicis on the Heineken business in India. They bring with them a wealth of knowledge in creating effective communication across consumer product categories in the country. We believe this association will give further impetus to the fastest growing beer brand in our port folio. We look forward to creating memorable work on Heineken in India in the years ahead.”
Publicis Ambience COO Paritosh Srivastava said, “We are very proud to be associated with an advertising hall of fame brand like Heineken. The challenge is to live up to the legacy or great work the brand has done globally and I am confident that together with the team we will meet it.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
